Marktanalyse - Biotechnology: Global Industry Guide

Datamonitor's Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).

* Includes a five-year forecast of the industry

Highlights

The global biotechnology market grew by 4% in 2009 to reach a value of $200.9 billion.

In 2014, the global biotechnology market is forecast to have a value of $318.4 billion, an increase of 58.5% since 2009.

Medical/Healthcare is the largest segment of the global biotechnology market, accounting for 66.2% of the market's total value.

Americas accounts for 48.4% of the global biotechnology market value.

Rapid market growth should encourage new players into the fray, but rivalry is assessed as moderate in a market where the typical player is an SME.

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this market from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2009 annual average exchange rates

TABLE OF CONTENTS

EXECUTIVE SUMMARY 2

INTRODUCTION 19

What is this report about? 19

Who is the target reader? 19

Market definition 19

GLOBAL BIOTECHNOLOGY 20

MARKET OVERVIEW 20

MARKET VALUE 21

MARKET SEGMENTATION I 22

MARKET SEGMENTATION II 23

FIVE FORCES ANALYSIS 24

MARKET FORECASTS 31

BIOTECHNOLOGY IN ASIAPACIFIC 33

MARKET OVERVIEW 33

MARKET VALUE 34

MARKET SEGMENTATION I 35

MARKET SEGMENTATION II 36

FIVE FORCES ANALYSIS 37

MARKET FORECASTS 45

BIOTECHNOLOGY IN EUROPE 47

MARKET OVERVIEW 47

MARKET VALUE 48

MARKET SEGMENTATION I 49

MARKET SEGMENTATION II 50

FIVE FORCES ANALYSIS 51

MARKET FORECASTS 59

BIOTECHNOLOGY IN BELGIUM 61

MARKET OVERVIEW 61

MARKET VALUE 62

MARKET SEGMENTATION I 63

MARKET SEGMENTATION II 64

FIVE FORCES ANALYSIS 65

MARKET FORECASTS 72

MACROECONOMIC INDICATORS 73

BIOTECHNOLOGY IN CANADA 76

MARKET OVERVIEW 76

MARKET VALUE 77

MARKET SEGMENTATION I 78

MARKET SEGMENTATION II 79

FIVE FORCES ANALYSIS 80

MARKET FORECASTS 86

MACROECONOMIC INDICATORS 87

BIOTECHNOLOGY IN CHINA 90

MARKET OVERVIEW 90

MARKET VALUE 91

MARKET SEGMENTATION I 92

MARKET SEGMENTATION II 93

FIVE FORCES ANALYSIS 94

MARKET FORECASTS 101

MACROECONOMIC INDICATORS 102

BIOTECHNOLOGY IN FRANCE 105

MARKET OVERVIEW 105

MARKET VALUE 106

MARKET SEGMENTATION I 107

MARKET SEGMENTATION II 108

FIVE FORCES ANALYSIS 109

MARKET FORECASTS 116

MACROECONOMIC INDICATORS 117

BIOTECHNOLOGY IN GERMANY 120

MARKET OVERVIEW 120

MARKET VALUE 121

MARKET SEGMENTATION I 122

MARKET SEGMENTATION II 123

FIVE FORCES ANALYSIS 124

MARKET FORECASTS 131

MACROECONOMIC INDICATORS 132

BIOTECHNOLOGY IN ITALY 135

MARKET OVERVIEW 135

MARKET VALUE 136

MARKET SEGMENTATION I 137

MARKET SEGMENTATION II 138

FIVE FORCES ANALYSIS 139

MARKET FORECASTS 146

MACROECONOMIC INDICATORS 147

BIOTECHNOLOGY IN JAPAN 150

MARKET OVERVIEW 150

MARKET VALUE 151

MARKET SEGMENTATION I 152

MARKET SEGMENTATION II 153

FIVE FORCES ANALYSIS 154

MARKET FORECASTS 161

MACROECONOMIC INDICATORS 162

BIOTECHNOLOGY IN THE NETHERLANDS 164

MARKET OVERVIEW 164

MARKET VALUE 165

MARKET SEGMENTATION I 166

MARKET SEGMENTATION II 167

FIVE FORCES ANALYSIS 168

MARKET FORECASTS 175

MACROECONOMIC INDICATORS 176

BIOTECHNOLOGY IN SPAIN 178

MARKET OVERVIEW 178

MARKET VALUE 179

MARKET SEGMENTATION I 180

MARKET SEGMENTATION II 181

FIVE FORCES ANALYSIS 182

MARKET FORECASTS 189

MACROECONOMIC INDICATORS 190

BIOTECHNOLOGY IN THE UNITED KINGDOM 193

MARKET OVERVIEW 193

MARKET VALUE 194

MARKET SEGMENTATION I 195

MARKET SEGMENTATION II 196

FIVE FORCES ANALYSIS 197

MARKET FORECASTS 204

MACROECONOMIC INDICATORS 205

BIOTECHNOLOGY IN THE UNITED STATES 208

MARKET OVERVIEW 208

MARKET VALUE 209

MARKET SEGMENTATION I 210

MARKET SEGMENTATION II 211

FIVE FORCES ANALYSIS 212

MARKET FORECASTS 219

MACROECONOMIC INDICATORS 220

COMPANY PROFILES 223

LEADING COMPANIES 223

APPENDIX 243

Data Research Methodology 243

About Datamonitor 244

Disclaimer 244



LIST OF TABLES

Table 1: Global biotechnology market value: $ billion, 2005—09 21

Table 2: Global biotechnology market segmentation I:% share, by value, 2009 22

Table 3: Global biotechnology market segmentation II: % share, by value, 2009 23

Table 4: Global biotechnology market value forecast: $ billion, 2009—14 31

Table 5: Asia-Pacific biotechnology market value: $ billion, 2005—09 34

Table 6: Asia-Pacific biotechnology market segmentation I:% share, by value, 2009 35

Table 7: Asia-Pacific biotechnology market segmentation II: % share, by value, 2009 36

Table 8: Asia-Pacific biotechnology market value forecast: $ billion, 2009—14 45

Table 9: Europe biotechnology market value: $ billion, 2005—09 48

Table 10: Europe biotechnology market segmentation I:% share, by value, 2009 49

Table 11: Europe biotechnology market segmentation II: % share, by value, 2009 50

Table 12: Europe biotechnology market value forecast: $ billion, 2009—14 59

Table 13: Belgium biotechnology market value: $ billion, 2005—09 62

Table 14: Belgium biotechnology market segmentation I:% share, by value, 2009 63

Table 15: Belgium biotechnology market segmentation II: % share, by value, 2009 64

Table 16: Belgium biotechnology market value forecast: $ billion, 2009—14 72

Table 17: Belgium size of population (million), 2005—09 73

Table 18: Belgium gdp (constant 2000 prices, $ billion), 2005—09 73

Table 19: Belgium gdp (current prices, $ billion), 2005—09 74

Table 20: Belgium inflation, 2005—09 74

Table 21: Belgium consumer price index (absolute), 2005—09 75

Table 22: Belgium exchange rate, 2005—09 75

Table 23: Canada biotechnology market value: $ billion, 2005—09 77

Table 24: Canada biotechnology market segmentation I:% share, by value, 2009 78

Table 25: Canada biotechnology market segmentation II: % share, by value, 2009 79

Table 26: Canada biotechnology market value forecast: $ billion, 2009—14 86

Table 27: Canada size of population (million), 2005—09 87

Table 28: Canada gdp (constant 2000 prices, $ billion), 2005—09 87

Table 29: Canada gdp (current prices, $ billion), 2005—09 88

Table 30: Canada inflation, 2005—09 88

Table 31: Canada consumer price index (absolute), 2005—09 89

Table 32: Canada exchange rate, 2005—09 89

Table 33: China biotechnology market value: $ billion, 2005—09 91

Table 34: China biotechnology market segmentation I:% share, by value, 2009 92

Table 35: China biotechnology market segmentation II: % share, by value, 2009 93

Table 36: China biotechnology market value forecast: $ billion, 2009—14 101

Table 37: China size of population (million), 2005—09 102

Table 38: China gdp (constant 2000 prices, $ billion), 2005—09 102

Table 39: China gdp (current prices, $ billion), 2005—09 103

Table 40: China inflation, 2005—09 103

Table 41: China consumer price index (absolute), 2005—09 104

Table 42: China exchange rate, 2005—09 104

Table 43: France biotechnology market value: $ billion, 2005—09 106

Table 44: France biotechnology market segmentation I:% share, by value, 2009 107

Table 45: France biotechnology market segmentation II: % share, by value, 2009 108

Table 46: France biotechnology market value forecast: $ billion, 2009—14 116

Table 47: France size of population (million), 2005—09 117

Table 48: France gdp (constant 2000 prices, $ billion), 2005—09 117

Table 49: France gdp (current prices, $ billion), 2005—09 118

Table 50: France inflation, 2005—09 118

Table 51: France consumer price index (absolute), 2005—09 119

Table 52: France exchange rate, 2005—09 119

Table 53: Germany biotechnology market value: $ billion, 2005—09 121

Table 54: Germany biotechnology market segmentation I:% share, by value, 2009 122

Table 55: Germany biotechnology market segmentation II: % share, by value, 2009 123

Table 56: Germany biotechnology market value forecast: $ billion, 2009—14 131

Table 57: Germany size of population (million), 2005—09 132

Table 58: Germany gdp (constant 2000 prices, $ billion), 2005—09 132

Table 59: Germany gdp (current prices, $ billion), 2005—09 133

Table 60: Germany inflation, 2005—09 133

Table 61: Germany consumer price index (absolute), 2005—09 134

Table 62: Germany exchange rate, 2005—09 134

Table 63: Italy biotechnology market value: $ billion, 2005—09 136

Table 64: Italy biotechnology market segmentation I:% share, by value, 2009 137

Table 65: Italy biotechnology market segmentation II: % share, by value, 2009 138

Table 66: Italy biotechnology market value forecast: $ billion, 2009—14 146

Table 67: Italy size of population (million), 2005—09 147

Table 68: Italy gdp (constant 2000 prices, $ billion), 2005—09 147

Table 69: Italy gdp (current prices, $ billion), 2005—09 148

Table 70: Italy inflation, 2005—09 148

Table 71: Italy consumer price index (absolute), 2005—09 149

Table 72: Italy exchange rate, 2005—09 149

Table 73: Japan biotechnology market value: $ billion, 2005—09 151

Table 74: Japan biotechnology market segmentation I:% share, by value, 2009 152

Table 75: Japan biotechnology market segmentation II: % share, by value, 2009 153

Table 76: Japan biotechnology market value forecast: $ billion, 2009—14 161

Table 77: Japan size of population (million), 2005—09 162

Table 78: Japan gdp (constant 2000 prices, $ billion), 2005—09 162

Table 79: Japan gdp (current prices, $ billion), 2005—09 162

Table 80: Japan inflation, 2005—09 163

Table 81: Japan consumer price index (absolute), 2005—09 163

Table 82: Japan exchange rate, 2005—09 163

Table 83: Netherlands biotechnology market value: $ million, 2005—09 165

Table 84: Netherlands biotechnology market segmentation I:% share, by value, 2009 166

Table 85: Netherlands biotechnology market segmentation II: % share, by value, 2009 167

Table 86: Netherlands biotechnology market value forecast: $ million, 2009—14 175

Table 87: Netherlands size of population (million), 2005—09 176

Table 88: Netherlands gdp (constant 2000 prices, $ billion), 2005—09 176

Table 89: Netherlands gdp (current prices, $ billion), 2005—09 176

Table 90: Netherlands inflation, 2005—09 177

Table 91: Netherlands consumer price index (absolute), 2005—09 177

Table 92: Netherlands exchange rate, 2005—09 177

Table 93: Spain biotechnology market value: $ billion, 2005—09 179

Table 94: Spain biotechnology market segmentation I:% share, by value, 2009 180

Table 95: Spain biotechnology market segmentation II: % share, by value, 2009 181

Table 96: Spain biotechnology market value forecast: $ billion, 2009—14 189

Table 97: Spain size of population (million), 2005—09 190

Table 98: Spain gdp (constant 2000 prices, $ billion), 2005—09 190

Table 99: Spain gdp (current prices, $ billion), 2005—09 191

Table 100: Spain inflation, 2005—09 191

Table 101: Spain consumer price index (absolute), 2005—09 192

Table 102: Spain exchange rate, 2005—09 192

Table 103: United Kingdom biotechnology market value: $ billion, 2005—09 194

Table 104: United Kingdom biotechnology market segmentation I:% share, by value, 2009 195

Table 105: United Kingdom biotechnology market segmentation II: % share, by value, 2009 196

Table 106: United Kingdom biotechnology market value forecast: $ billion, 2009—14 204

Table 107: United Kingdom size of population (million), 2005—09 205

Table 108: United Kingdom gdp (constant 2000 prices, $ billion), 2005—09 205

Table 109: United Kingdom gdp (current prices, $ billion), 2005—09 206

Table 110: United Kingdom inflation, 2005—09 206

Table 111: United Kingdom consumer price index (absolute), 2005—09 207

Table 112: United Kingdom exchange rate, 2005—09 207

Table 113: United States biotechnology market value: $ billion, 2005—09 209

Table 114: United States biotechnology market segmentation I:% share, by value, 2009 210

Table 115: United States biotechnology market segmentation II: % share, by value, 2009 211

Table 116: United States biotechnology market value forecast: $ billion, 2009—14 219

Table 117: United States size of population (million), 2005—09 220

Table 118: United States gdp (constant 2000 prices, $ billion), 2005—09 220

Table 119: United States gdp (current prices, $ billion), 2005—09 221

Table 120: United States inflation, 2005—09 221

Table 121: United States consumer price index (absolute), 2005—09 222

Table 122: United States exchange rate, 2005—09 222

Table 123: Merck KGaA: key facts 223

Table 124: Merck KGaA: key financials ($) 226

Table 125: Merck KGaA: key financials (€) 226

Table 126: Merck KGaA: key financial ratios 227

Table 127: Novartis AG: key facts 229

Table 128: Novartis AG: key financials ($) 231

Table 129: Novartis AG: key financial ratios 231

Table 130: Pfizer Inc.: key facts 234

Table 131: Pfizer Inc.: key financials ($) 235

Table 132: Pfizer Inc.: key financial ratios 236

Table 133: AstraZeneca PLC: key facts 238

Table 134: AstraZeneca PLC: key financials ($) 240

Table 135: AstraZeneca PLC: key financial ratios 241





LIST OF FIGURES

Figure 1: Global biotechnology market value: $ billion, 2005—09 21

Figure 2: Global biotechnology market segmentation I:% share, by value, 2009 22

Figure 3: Global biotechnology market segmentation II: % share, by value, 2009 23

Figure 4: Forces driving competition in the global biotechnology market, 2009 24

Figure 5: Drivers of buyer power in the global biotechnology market, 2009 25

Figure 6: Drivers of supplier power in the global biotechnology market, 2009 26

Figure 7: Factors influencing the likelihood of new entrants in the global biotechnology market, 2009 27

Figure 8: Factors influencing the threat of substitutes in the global biotechnology market, 2009 29

Figure 9: Drivers of degree of rivalry in the global biotechnology market, 2009 30

Figure 10: Global biotechnology market value forecast: $ billion, 2009—14 32

Figure 11: Asia-Pacific biotechnology market value: $ billion, 2005—09 34

Figure 12: Asia-Pacific biotechnology market segmentation I:% share, by value, 2009 35

Figure 13: Asia-Pacific biotechnology market segmentation II: % share, by value, 2009 36

Figure 14: Forces driving competition in the biotechnology market in Asia-Pacific, 2009 37

Figure 15: Drivers of buyer power in the biotechnology market in Asia-Pacific, 2009 38

Figure 16: Drivers of supplier power in the biotechnology market in Asia-Pacific, 2009 40

Figure 17: Factors influencing the likelihood of new entrants in the biotechnology market in Asia-Pacific, 2009 41

Figure 18: Factors influencing the threat of substitutes in the biotechnology market in Asia-Pacific, 2009 43

Figure 19: Drivers of degree of rivalry in the biotechnology market in Asia-Pacific, 2009 44

Figure 20: Asia-Pacific biotechnology market value forecast: $ billion, 2009—14 46

Figure 21: Europe biotechnology market value: $ billion, 2005—09 48

Figure 22: Europe biotechnology market segmentation I:% share, by value, 2009 49

Figure 23: Europe biotechnology market segmentation II: % share, by value, 2009 50

Figure 24: Forces driving competition in the biotechnology market in Europe, 2009 51

Figure 25: Drivers of buyer power in the biotechnology market in Europe, 2009 52

Figure 26: Drivers of supplier power in the biotechnology market in Europe, 2009 54

Figure 27: Factors influencing the likelihood of new entrants in the biotechnology market in Europe, 2009 55

Figure 28: Factors influencing the threat of substitutes in the biotechnology market in Europe, 2009 57

Figure 29: Drivers of degree of rivalry in the biotechnology market in Europe, 2009 58

Figure 30: Europe biotechnology market value forecast: $ billion, 2009—14 60

Figure 31: Belgium biotechnology market value: $ billion, 2005—09 62

Figure 32: Belgium biotechnology market segmentation I:% share, by value, 2009 63

Figure 33: Belgium biotechnology market segmentation II: % share, by value, 2009 64

Figure 34: Forces driving competition in the biotechnology market in Belgium, 2009 65

Figure 35: Drivers of buyer power in the biotechnology market in Belgium, 2009 66

Figure 36: Drivers of supplier power in the biotechnology market in Belgium, 2009 67

Figure 37: Factors influencing the likelihood of new entrants in the biotechnology market in Belgium, 2009 68

Figure 38: Factors influencing the threat of substitutes in the biotechnology market in Belgium, 2009 70

Figure 39: Drivers of degree of rivalry in the biotechnology market in Belgium, 2009 71

Figure 40: Belgium biotechnology market value forecast: $ billion, 2009—14 72

Figure 41: Canada biotechnology market value: $ billion, 2005—09 77

Figure 42: Canada biotechnology market segmentation I:% share, by value, 2009 78

Figure 43: Canada biotechnology market segmentation II: % share, by value, 2009 79

Figure 44: Forces driving competition in the biotechnology market in Canada, 2009 80

Figure 45: Drivers of buyer power in the biotechnology market in Canada, 2009 81

Figure 46: Drivers of supplier power in the biotechnology market in Canada, 2009 82

Figure 47: Factors influencing the likelihood of new entrants in the biotechnology market in Canada, 2009 83

Figure 48: Factors influencing the threat of substitutes in the biotechnology market in Canada, 2009 84

Figure 49: Drivers of degree of rivalry in the biotechnology market in Canada, 2009 85

Figure 50: Canada biotechnology market value forecast: $ billion, 2009—14 86

Figure 51: China biotechnology market value: $ billion, 2005—09 91

Figure 52: China biotechnology market segmentation I:% share, by value, 2009 92

Figure 53: China biotechnology market segmentation II: % share, by value, 2009 93

Figure 54: Forces driving competition in the biotechnology market in China, 2009 94

Figure 55: Drivers of buyer power in the biotechnology market in China, 2009 95

Figure 56: Drivers of supplier power in the biotechnology market in China, 2009 96

Figure 57: Factors influencing the likelihood of new entrants in the biotechnology market in China, 2009 97

Figure 58: Factors influencing the threat of substitutes in the biotechnology market in China, 2009 99

Figure 59: Drivers of degree of rivalry in the biotechnology market in China, 2009 100

Figure 60: China biotechnology market value forecast: $ billion, 2009—14 101

Figure 61: France biotechnology market value: $ billion, 2005—09 106

Figure 62: France biotechnology market segmentation I:% share, by value, 2009 107

Figure 63: France biotechnology market segmentation II: % share, by value, 2009 108

Figure 64: Forces driving competition in the biotechnology market in France, 2009 109

Figure 65: Drivers of buyer power in the biotechnology market in France, 2009 110

Figure 66: Drivers of supplier power in the biotechnology market in France, 2009 111

Figure 67: Factors influencing the likelihood of new entrants in the biotechnology market in France, 2009 112

Figure 68: Factors influencing the threat of substitutes in the biotechnology market in France, 2009 114

Figure 69: Drivers of degree of rivalry in the biotechnology market in France, 2009 115

Figure 70: France biotechnology market value forecast: $ billion, 2009—14 116

Figure 71: Germany biotechnology market value: $ billion, 2005—09 121

Figure 72: Germany biotechnology market segmentation I:% share, by value, 2009 122

Figure 73: Germany biotechnology market segmentation II: % share, by value, 2009 123

Figure 74: Forces driving competition in the biotechnology market in Germany, 2009 124

Figure 75: Drivers of buyer power in the biotechnology market in Germany, 2009 125

Figure 76: Drivers of supplier power in the biotechnology market in Germany, 2009 126

Figure 77: Factors influencing the likelihood of new entrants in the biotechnology market in Germany, 2009 127

Figure 78: Factors influencing the threat of substitutes in the biotechnology market in Germany, 2009 129

Figure 79: Drivers of degree of rivalry in the biotechnology market in Germany, 2009 130

Figure 80: Germany biotechnology market value forecast: $ billion, 2009—14 131

Figure 81: Italy biotechnology market value: $ billion, 2005—09 136

Figure 82: Italy biotechnology market segmentation I:% share, by value, 2009 137

Figure 83: Italy biotechnology market segmentation II: % share, by value, 2009 138

Figure 84: Forces driving competition in the biotechnology market in Italy, 2009 139

Figure 85: Drivers of buyer power in the biotechnology market in Italy, 2009 140

Figure 86: Drivers of supplier power in the biotechnology market in Italy, 2009 141

Figure 87: Factors influencing the likelihood of new entrants in the biotechnology market in Italy, 2009 142

Figure 88: Factors influencing the threat of substitutes in the biotechnology market in Italy, 2009 144

Figure 89: Drivers of degree of rivalry in the biotechnology market in Italy, 2009 145

Figure 90: Italy biotechnology market value forecast: $ billion, 2009—14 146

Figure 91: Japan biotechnology market value: $ billion, 2005—09 151

Figure 92: Japan biotechnology market segmentation I:% share, by value, 2009 152

Figure 93: Japan biotechnology market segmentation II: % share, by value, 2009 153

Figure 94: Forces driving competition in the biotechnology market in Japan, 2009 154

Figure 95: Drivers of buyer power in the biotechnology market in Japan, 2009 155

Figure 96: Drivers of supplier power in the biotechnology market in Japan, 2009 156

Figure 97: Factors influencing the likelihood of new entrants in the biotechnology market in Japan, 2009 157

Figure 98: Factors influencing the threat of substitutes in the biotechnology market in Japan, 2009 159

Figure 99: Drivers of degree of rivalry in the biotechnology market in Japan, 2009 160

Figure 100: Japan biotechnology market value forecast: $ billion, 2009—14 161

Figure 101: Netherlands biotechnology market value: $ million, 2005—09 165

Figure 102: Netherlands biotechnology market segmentation I:% share, by value, 2009 166

Figure 103: Netherlands biotechnology market segmentation II: % share, by value, 2009 167

Figure 104: Forces driving competition in the biotechnology market in the Netherlands, 2009 168

Figure 105: Drivers of buyer power in the biotechnology market in the Netherlands, 2009 169

Figure 106: Drivers of supplier power in the biotechnology market in the Netherlands, 2009 170

Figure 107: Factors influencing the likelihood of new entrants in the biotechnology market in the Netherlands, 2009 171

Figure 108: Factors influencing the threat of substitutes in the biotechnology market in the Netherlands, 2009 173

Figure 109: Drivers of degree of rivalry in the biotechnology market in the Netherlands, 2009 174

Figure 110: Netherlands biotechnology market value forecast: $ million, 2009—14 175

Figure 111: Spain biotechnology market value: $ billion, 2005—09 179

Figure 112: Spain biotechnology market segmentation I:% share, by value, 2009 180

Figure 113: Spain biotechnology market segmentation II: % share, by value, 2009 181

Figure 114: Forces driving competition in the biotechnology market in Spain, 2009 182

Figure 115: Drivers of buyer power in the biotechnology market in Spain, 2009 183

Figure 116: Drivers of supplier power in the biotechnology market in Spain, 2009 184

Figure 117: Factors influencing the likelihood of new entrants in the biotechnology market in Spain, 2009 185

Figure 118: Factors influencing the threat of substitutes in the biotechnology market in Spain, 2009 187

Figure 119: Drivers of degree of rivalry in the biotechnology market in Spain, 2009 188

Figure 120: Spain biotechnology market value forecast: $ billion, 2009—14 189

Figure 121: United Kingdom biotechnology market value: $ billion, 2005—09 194

Figure 122: United Kingdom biotechnology market segmentation I:% share, by value, 2009 195

Figure 123: United Kingdom biotechnology market segmentation II: % share, by value, 2009 196

Figure 124: Forces driving competition in the biotechnology market in the United Kingdom, 2009 197

Figure 125: Drivers of buyer power in the biotechnology market in the United Kingdom, 2009 198

Figure 126: Drivers of supplier power in the biotechnology market in the United Kingdom, 2009 200

Figure 127: Factors influencing the likelihood of new entrants in the biotechnology market in the United Kingdom, 2009 201

Figure 128: Factors influencing the threat of substitutes in the biotechnology market in the United Kingdom, 2009 202

Figure 129: Drivers of degree of rivalry in the biotechnology market in the United Kingdom, 2009 203

Figure 130: United Kingdom biotechnology market value forecast: $ billion, 2009—14 204

Figure 131: United States biotechnology market value: $ billion, 2005—09 209

Figure 132: United States biotechnology market segmentation I:% share, by value, 2009 210

Figure 133: United States biotechnology market segmentation II: % share, by value, 2009 211

Figure 134: Forces driving competition in the biotechnology market in the United States, 2009 212

Figure 135: Drivers of buyer power in the biotechnology market in the United States, 2009 213

Figure 136: Drivers of supplier power in the biotechnology market in the United States, 2009 214

Figure 137: Factors influencing the likelihood of new entrants in the biotechnology market in the United States, 2009 215

Figure 138: Factors influencing the threat of substitutes in the biotechnology market in the United States, 2009 217

Figure 139: Drivers of degree of rivalry in the biotechnology market in the United States, 2009 218

Figure 140: United States biotechnology market value forecast: $ billion, 2009—14 219

Figure 141: Merck KGaA: revenues & profitability 227

Figure 142: Merck KGaA: assets & liabilities 228

Figure 143: Novartis AG: revenues & profitability 232

Figure 144: Novartis AG: assets & liabilities 233

Figure 145: Pfizer Inc.: revenues & profitability 236

Figure 146: Pfizer Inc.: assets & liabilities 237

Figure 147: AstraZeneca PLC: revenues & profitability 241

Figure 148: AstraZeneca PLC: assets & liabilities 242

• Biomaterials Market – Global Forecasts to 2017
• Protein Engineering Market - Global Forecast to 2017
• Biotechnology in Asia-Pacific
• Biotechnology in Belgium
• Biotechnology in Canada
• Biotechnology in China
• Biotechnology in Europe
• Biotechnology in France
• Biotechnology in Germany
• Biotechnology in Italy
• Biotechnology in Japan
• Biotechnology in Spain
• Biotechnology in the Netherlands
• Biotechnology in the United Kingdom
• Biotechnology in the United States
• Biotechnology: Global Industry Guide
• Global Biotechnology
• Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies
• Home Improvement and Gardening Supplies Retailers in Malaysia
• Biotechnology Pharmaceutical Market in US 2009-2013